Skip to main content
Tech.euFundingExplorerBeta

Healthtech funding in H2 2023

European Healthtech startup funding raised during H2 2023.

In H2 2023, 222 European Healthtech companies closed 226 funding rounds and raised €4.5B in equity funding (excluding debt and grants), up 29.3% versus H2 2022. Debt rounds added €72M. Netherlands led by capital raised, and High-Tech Gründerfonds (HTGF) was the most active investor. Data as of 20 Nov 2026.

Equity funding
€4.5B
+29.3% vs H2 2022 · excl. debt & grants · +€72M debt
Funding rounds
226
-30.9% vs H2 2022
Companies
222
Top country
Netherlands
Rank among sectors
#6
9.8% of sector funding
Debt financing
€72M
1.6% of total
Top-10 round share
76.2%
of disclosed capital
Rounds ≥ €100M
4

Funding by month

€ raised vs rounds, by month
Healthtech — funding by month, H2 2023 — interactive chart.
Data table
FundingRounds
Jul€279M36
Aug€3.0B30
Sep€391M39
Oct€321M44
Nov€286M45
Dec€251M32

Top countries

by € raised
Healthtech — top countries by capital, H2 2023 — interactive chart.
Data table
Healthtech — top countries by capital, H2 2023
Netherlands€2.7B
UK€881M
France€295M
Denmark€163M
Belgium€119M
Switzerland€91M
Germany€87M
Sweden€82M

Stage mix

by € raised
Healthtech — stage mix, H2 2023 — interactive chart.
Data table
Healthtech — stage mix, H2 2023
Other€3.6B
Series A€423M
Series B€207M
Series C€121M
Seed€95M
Debt€72M
Grant€25M
Pre-Seed€13M
Early VC€1.0M
Series D+€716k

Exits & M&A

15 Acquisition

15 exits · €6.3B disclosed.

AbcamAcquisitionAug 2023€5.2B
MedAllianceAcquisitionOct 2023€1.1B

Top deals

largest disclosed rounds in H2 2023
CompanyStageDateAmount
PhilipsOtherAug 2023€2.6B
Compass PathwaysOtherAug 2023€261M
CMR SurgicalOtherSep 2023€154M
AqemiaOtherDec 2023€129M
Agomab TherapeuticsSeries COct 2023€95M
EyeBiotechSeries ANov 2023€61M
Neko HealthSeries AJul 2023€60M
CortiSeries BSep 2023€56M
MinervaXOtherOct 2023€54M
CausalySeries BJul 2023€54M
Lightcast DiscoverySeries BAug 2023€45M
In OvoDebtNov 2023€40M
Automata TechnologiesOtherOct 2023€38M
MYCB1OtherSep 2023€31M
BactolifeSeries AAug 2023€30M

Top investors

most active in H2 2023, by deal count